199380
For the active immunisation of cattle against • Parainfluenza3 virus (PI3 virus), to reduce infections. • Bovine Respiratory Syncytial Virus (BRSV) to reduce infection and clinical signs. • Mannheimia (Pasteurella) haemolytica serotype A1, to reduce infection, mortality, clinical signs, lung lesions and bacterial invasion of the lung caused by serotypes A1 and A6. Cross-reactive immunity to the A6 serotype of M. haemolytica has been demonstrated in a challenge experiment under laboratory conditions after a primary course of vaccination. Approximately two weeks after completion of the basic immunisation programme, the humoral immune response against BRS-Virus and PI3-Virus is at its highest level. The duration of protective immunity has not been established in challenge experiments. Dosage & Administration: Vaccination dose: 5 ml by subcutaneous injection at the side of the neck.
